Patients will be interviewed fourteen days after procedure and asked how many opioid pills they have taken since being discharged form the hospitals
| Group | Value | 95% CI |
|---|---|---|
| Control | 46 | 37.5 – 75 |
| Opioid Sparing | 15 | 11 – 22.5 |
| Zero Opioid | 0 | 0 – 0 |
Last reviewed · How we verify
Toward Zero Prescribed Opioids for Outpatient General Surgery
Phase 4 trial testing Oxycodone in Opioid Misuse and Addiction in 129 participants. Completed in 15 March 2023.
| Lead sponsor | Thomas Jefferson University |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 129 |
| Start date | 1 November 2019 |
| Primary completion | 30 July 2021 |
| Estimated completion | 15 March 2023 |
| Sites | 1 location across United States |
Thomas Jefferson University
Adults 18 to 99, any sex, with Opioid Misuse and Addiction or Pain. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Patients will be interviewed fourteen days after procedure and asked how many opioid pills they have taken since being discharged form the hospitals
| Group | Value | 95% CI |
|---|---|---|
| Control | 46 | 37.5 – 75 |
| Opioid Sparing | 15 | 11 – 22.5 |
| Zero Opioid | 0 | 0 – 0 |
Patient will be asked to rank their satisfaction scores on a scale from 1 - 10 (with 1 being extremely dissatisfied and 10 being extremely satisfied) since discharge from the hospital
| Group | Value | 95% CI |
|---|---|---|
| Control | 10 | 9 – 10 |
| Opioid Sparing | 10 | 9 – 10 |
| Zero Opioid | 10 | 8.5 – 10 |
Investigators have created an opioid reduction "package" which includes patient education, non-narcotic pain control instructions, and limited (or no) opioid pain prescriptions provided at discharge in an attempt to reduce the number of opioid consumption after outpatient general surgery.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Trials testing the same drug.
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05327777.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing